Prototype development of MAB VRC114
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY1890007
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $5,091,571
Award facts
- Contract value 61% obligated
-
- $5,091,570.72 Current, with exercised options
- $8,363,045.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,173 | |
| Supplemental Agreement for work within scope | $2,100 | |
| Supplemental Agreement for work within scope | $4,200 | |
| Supplemental Agreement for work within scope | $1,400 | |
| Supplemental Agreement for work within scope | $1,400 | |
| Supplemental Agreement for work within scope | $1,400 | |
| Supplemental Agreement for work within scope | $45,635 | |
| Supplemental Agreement for work within scope | $800,000 | |
| Modification | $165,000 | |
| Funding Only Action | $3,003,438 | |
| Funding Only Action | $1,065,825 |
Show all 11
About this award
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $8,363,045 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., for the prototype development of a monoclonal antibody (MAB) countermeasure designated VRC114. The contract does not have a set-aside designation. Resilience Government Services is a technology-focused biomanufacturing company that has previously supported the Department of Defense and Department of Health and Human Services with medical countermeasure development, clinical trials, and pharmaceutical manufacturing. This contract award is associated with two of Resilience's active Indefinite Delivery Vehicles (IDVs) from the Army Acquisition Support Center, including a $5.7 million Other Transaction IDIQ focused on transferring capabilities to demonstrate medical countermeasure provision, and a $249 million single-award Indefinite Delivery Contract supporting chemical and biological defense programs. Task orders under the IDC are advancing the VRC114 MAB countermeasure through clinical trials and regulatory approval.
Quick answers
Who was awarded contract W911QY1890007?
W911QY1890007 was awarded to Resilience Government Services, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 9, 2018.
How much is contract W911QY1890007 worth?
The government has obligated $5,091,571 on W911QY1890007. Its potential value, with all options, is $8,363,045.
Which agency awarded contract W911QY1890007?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY1890007, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY1890007 competed?
The extent of competition for W911QY1890007 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award